Bio-Techne Corporation (TECH)
NASDAQ·Healthcare·Biotechnology
$53.58
-2.78%
Mkt Cap $9.17B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 4, 2026 | $290.47M | $295.88M | +1.86% | $0.43 | $0.46 | +6.98% | — | — |
| Q4 2025 Nov 5, 2025 | $291.32M | $286.56M | -1.63% | $0.42 | $0.42 | -0.33% | — | — |
| Q3 2025 Aug 6, 2025 | $294.63M | $316.96M | +7.58% | $0.50 | $0.53 | +6.13% | — | — |
| Q2 2025 May 7, 2025 | $325.45M | $316.18M | -2.85% | $0.51 | $0.56 | +10.24% | — | — |
| Q1 2025 Feb 5, 2025 | $317.53M | $297.03M | -6.46% | $0.39 | $0.42 | +8.75% | — | — |
| Q4 2024 Oct 30, 2024 | $280.26M | $289.50M | +3.30% | $0.38 | $0.42 | +10.53% | — | — |
| Q3 2024 Aug 7, 2024 | $306.49M | $306.10M | -0.13% | $0.49 | $0.49 | -0.99% | — | — |
| Q2 2024 May 1, 2024 | $306.07M | $303.43M | -0.86% | $0.45 | $0.48 | +6.01% | — | — |
| Q1 2024 Feb 1, 2024 | $277.77M | $272.60M | -1.86% | $0.41 | $0.40 | -2.96% | — | — |
| Q4 2023 Oct 31, 2023 | $291.39M | $276.94M | -4.96% | $0.44 | $0.41 | -6.82% | — | — |
| Q3 2023 Aug 8, 2023 | $307.25M | $301.32M | -1.93% | $0.55 | $0.55 | +0.00% | — | — |
| Q2 2023 May 3, 2023 | $296.66M | $294.15M | -0.85% | $0.53 | $0.53 | +0.00% | — | — |
| Q1 2023 Feb 2, 2023 | $288.80M | $271.58M | -5.96% | $0.49 | $0.47 | -3.71% | — | — |
| Q4 2022 Nov 1, 2022 | $281.83M | $269.65M | -4.32% | $0.59 | $0.45 | -23.73% | — | — |
| Q3 2022 Aug 4, 2022 | $286.71M | $288.23M | +0.53% | $0.52 | $0.51 | -1.73% | — | — |
| Q2 2022 May 4, 2022 | $279.27M | $290.38M | +3.98% | $0.50 | $0.54 | +8.15% | — | — |
| Q1 2022 Feb 1, 2022 | $266.44M | $269.28M | +1.06% | $0.45 | $0.47 | +4.44% | — | — |
| Q4 2021 Nov 2, 2021 | $252.80M | $257.72M | +1.95% | $0.43 | $0.46 | +6.98% | — | — |
| Q3 2021 Aug 5, 2021 | $259.03M | $259.03M | +0.00% | $0.42 | $0.47 | +11.90% | — | — |
| Q2 2021 May 6, 2021 | $228.22M | $243.55M | +6.72% | $0.38 | $0.45 | +18.42% | — | — |